Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-22

Clinical Trial Update: A Clinical Study of Remimazolam Tosilate in Patients Undergoing Bronchoscopy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating remimazolam tosilate for sedation in patients undergoing bronchoscopy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remimazolam Tosilate (remimazolam)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Sedation | Phase 3 | Status: COMPLETED